Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Products/Therapies
1.2.2. Surgery
1.2.3. Application
1.2.4. End use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Peripheral Nerve Injury Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. U.S. Peripheral Nerve Injury Market: Products/Therapies Business Analysis
4.1. Products/Therapies Market Share, 2024 & 2030
4.2. Products/Therapies Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Products/Therapies, 2018 to 2030 (USD Million)
4.4. Nerve Grafting
4.4.1. Nerve Grafting Market, 2018 - 2030 (USD Million)
4.4.2. Autograft
4.4.2.1. Autograft Market, 2018 - 2030 (USD Million)
4.4.3. Allograft
4.4.3.1. Allograft Market, 2018 - 2030 (USD Million)
4.4.4. Stem Cell Therapy
4.4.4.1. Stem Cell Therapy Market, 2018 - 2030 (USD Million)
4.5. Biomaterial
4.5.1. Biomaterial Market, 2018 - 2030 (USD Million)
4.5.2. Nerve Conduit
4.5.2.1. Nerve Conduit Market, 2018 - 2030 (USD Million)
4.5.3. Nerve Protector
4.5.3.1. Nerve Protector Market, 2018 - 2030 (USD Million)
4.5.4. Nerve Connector
4.5.4.1. Nerve Connector Market, 2018 - 2030 (USD Million)
4.5.5. Nerve Wraps
4.5.5.1. Nerve Wraps Market, 2018 - 2030 (USD Million)
Chapter 5. U.S. Peripheral Nerve Injury Market: Surgery Business Analysis
5.1. Surgery Market Share, 2024 & 2030
5.2. Surgery Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Surgery, 2018 to 2030 (USD Million)
5.4. Direct Nerve Repair
5.4.1. Direct Nerve Repair Market, 2018 - 2030 (USD Million)
5.5. Nerve Grafting
5.5.1. Nerve Grafting Market, 2018 - 2030 (USD Million)
5.6. Stem Cell Therapy
5.6.1. Stem Cell Therapy Market, 2018 - 2030 (USD Million)
5.7. Internal Neurolysis
5.7.1. Internal Neurolysis Market, 2018 - 2030 (USD Million)
5.8. Neurorrhaphy
5.8.1. Neurorrhaphy Market, 2018 - 2030 (USD Million)
Chapter 6. U.S. Peripheral Nerve Injury Market: Application Business Analysis
6.1. Application Market Share, 2024 & 2030
6.2. Application Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Upper Extremities
6.4.1. Upper Extremities Market, 2018 - 2030 (USD Million)
6.5. Lower Extremities
6.5.1. Lower Extremities Market, 2018 - 2030 (USD Million)
Chapter 7. U.S. Peripheral Nerve Injury Market: End Use Business Analysis
7.1. End Use Market Share, 2024 & 2030
7.2. End Use Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Hospitals
7.4.1. Hospitals Market, 2018 - 2030 (USD Million)
7.5. Clinics
7.5.1. Clinics Market, 2018 - 2030 (USD Million)
7.6. Ambulatory Surgical Centers
7.6.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
7.7. Others
7.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Axogen Corporation.
8.5.1.1. Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Stryker
8.5.2.1. Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Regenity
8.5.3.1. Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Integra LifeSciences Corporation.
8.5.4.1. Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. TOYOBO CO., LTD.
8.5.5.1. Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Alafair Biosciences, Inc.
8.5.6.1. Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. SYNOVIS MICRO COMPANIES ALLIANCE, INC., (BAXTER INTERNATIONAL INC.)
8.5.7.1. Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. U.S. peripheral nerve injury market, by product/therapies, 2018 - 2030 (USD Million)
Table 4. U.S. peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
Table 5. U.S. peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
Table 6. U.S. peripheral nerve injury market, end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 U.S. peripheral nerve injury market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Market snapshot
Fig. 8 Segment outlook
Fig. 9 Competitive landscape
Fig. 10 U.S. peripheral nerve injury market dynamics
Fig. 11 U.S. peripheral nerve injury market: Porter’s five forces analysis
Fig. 12 U.S. peripheral nerve injury market: PESTLE analysis
Fig. 13 U.S. peripheral nerve injury market: Products/therapies segment dashboard
Fig. 14 U.S. peripheral nerve injury market: Products/therapies market share analysis, 2024 & 2030
Fig. 15 Nerve grafting market, 2018 - 2030 (USD Million)
Fig. 16 Autograft market, 2018 - 2030 (USD Million)
Fig. 17 Allograft market, 2018 - 2030 (USD Million)
Fig. 18 Stem cell therapy market, 2018 - 2030 (USD Million)
Fig. 19 Biomaterial market, 2018 - 2030 (USD Million)
Fig. 20 Nerve conduit market, 2018 - 2030 (USD Million)
Fig. 21 Nerve protector market, 2018 - 2030 (USD Million)
Fig. 22 Nerve connector market, 2018 - 2030 (USD Million)
Fig. 23 U.S. peripheral nerve injury market: Surgery segment dashboard
Fig. 24 U.S. peripheral nerve injury market: Surgery market share analysis, 2024 & 2030
Fig. 25 Direct nerve repair market, 2018 - 2030 (USD Million)
Fig. 26 Nerve grafting market, 2018 - 2030 (USD Million)
Fig. 27 Stem cell therapy market, 2018 - 2030 (USD Million)
Fig. 28 Carpal tunnel release market, 2018 - 2030 (USD Million)
Fig. 29 Internal neurolysis market, 2018 - 2030 (USD Million)
Fig. 30 Neurorrhaphy market, 2018 - 2030 (USD Million)
Fig. 31 U.S. peripheral nerve injury market: Application segment dashboard
Fig. 32 U.S. peripheral nerve injury market: Application market share analysis, 2024 & 2030
Fig. 33 Upper extremities market, 2018 - 2030 (USD Million)
Fig. 34 Lower extremities market, 2018 - 2030 (USD Million)
Fig. 35 U.S. peripheral nerve injury market: End use segment dashboard
Fig. 36 U.S. peripheral nerve injury market: End use market share analysis, 2024 & 2030
Fig. 37 Hospitals market, 2018 - 2030 (USD Million)
Fig. 38 Clinics market, 2018 - 2030 (USD Million)
Fig. 39 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
Fig. 40 Others market, 2018 - 2030 (USD Million)
Fig. 41 Company categorization
Fig. 42 Company market position analysis
Fig. 43 Strategic framework